Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • mylan

    Tag: mylan

    You Searched For "mylan"
    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Medical Dialogues Bureau29 March 2020 1:32 PM IST
    Hertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir

    Medical Dialogues Bureau29 March 2020 1:19 PM IST
    New Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus

    Medical Dialogues Bureau28 March 2020 1:30 PM IST
    Hertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
    Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

    Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi

    Medical Dialogues Bureau12 March 2020 11:29 AM IST
    Insulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
    USFDA Accepts Biocon, Mylans application for review of   Proposed Biosimilar of Bevacizumab

    USFDA Accepts Biocon, Mylan's application for review of Proposed Biosimilar of Bevacizumab

    Medical Dialogues Bureau10 March 2020 1:15 PM IST
    Biocon Ltd. and Mylan N.V. announced that the U.S. Food and Drug Administration (FDA) has accepted Mylan's Biologics License Application (BLA)...
    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Medical Dialogues Bureau29 Feb 2020 9:30 AM IST
    Although heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
    Sanjeev Narula CFO Pfizer Upjohn  appointed as incoming CFO of Viatris

    Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris

    Medical Dialogues Bureau28 Feb 2020 1:45 PM IST
    Viatris is the new company that will result from the planned combination of Mylan and Upjohn
    Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh

    Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh

    Medical Dialogues Bureau25 Feb 2020 4:28 PM IST
    Beximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Sanofi asks US court to halt diabetes drug patent fight with Mylan

    Medical Dialogues Bureau12 Feb 2020 10:30 AM IST
    In a stay application filed on Friday, Sanofi said a recent U.S. Court of Appeals for the Federal Circuit decision upholding the invalidation of two...
    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    NPPA fixes price of 21 formulations including diabetes drugs, others; Details

    Farhat Nasim11 Feb 2020 12:17 PM IST
    New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Farhat Nasim3 Feb 2020 1:41 PM IST
    New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 9:45 AM IST
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok